Floatz logo

8 assets in High Grade Malignant Neoplasm

Therapeutic assets addressing High Grade Malignant Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Pembrolizumab
High Grade Malignant Neoplasm
Kling Biotherapeutics B.V.P1/2B (60)
Immunoglobulin Half-Ig G1-Kappa/Scfv-H-Ch2-Ch3, Anti-(Homo Sapiens Ctla4 (Cytotoxic T-Lymphocyte-Associated Protein 4, Cd152)) And Anti-(Homo Sapienspdcd1 (Programmed Cell Death 1, Pd-1, Pd1, Cd279)), Monoclonal Antibody, Bispecific
High Grade Malignant Neoplasm
M.D. Anderson Cancer CenterP2CCC (53)
kba1412
High Grade Malignant Neoplasm
Kling Biotherapeutics B.V.P1CC (47)
Carboplatin
High Grade Malignant Neoplasm
AstraZenecaP1CC (43)
Ceralasertib
High Grade Malignant Neoplasm
AstraZenecaP1CC (43)
Durvalumab
High Grade Malignant Neoplasm
AstraZenecaP1CC (43)
Olaparib
High Grade Malignant Neoplasm
AstraZenecaP1CC (43)
Saruparib
High Grade Malignant Neoplasm
AstraZenecaP1CC (43)